Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCEAN: Omega 3 for Depression in Heart Failure
NCT02057406Phase 3Completed
- Start
- May 2014
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) (3 arms). Primary endpoints: Hamilton Depression Rating Scale at 12 weeks and Red Blood Cell/Plasma EPA Values at 12 weeks. Started May 2014; status: completed.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02057406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057406.